Patents by Inventor James HILGER

James HILGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240009197
    Abstract: Disclosed herein is a method for the prevention, delay of progression or treatment of indolent or aggressive B-cell lymphomas in an individual in need thereof, comprising administering a Btk inhibitor (in particularly (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo-[1,5-a]pyrimidine-3-carboxamide or a pharmaceutically acceptable salt thereof) in combination with an anti-PD-1 antibody. The potent and selective BTK inhibitor in combination with the anti-PD-1 antibody have a manageable toxicity profile in patients with indolent and aggressive lymphomas.
    Type: Application
    Filed: August 15, 2023
    Publication date: January 11, 2024
    Inventors: James HILGER, Xiaoping ZHANG, Shibao FENG, Sunhee RO, Jane HUANG
  • Patent number: 11786529
    Abstract: Disclosed herein is a method for the prevention, delay of progression or treatment of indolent or aggressive B-cell lymphomas in an individual in need thereof, comprising administering a Btk inhibitor (in particularly (S)-7-(1-actyloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo-[1,5-a]pyrimidine-3-carboxamide or a pharmaceutically acceptable salt thereof) in combination with an anti-PD-1 antibody. The potent and selective BTK inhibitor in combination with the anti-PD-1 antibody have a manageable toxicity profile in patients with indolent and aggressive lymphomas.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: October 17, 2023
    Assignee: BEIGENE SWITZERLAND GMBH
    Inventors: James Hilger, Xiaoping Zhang, Shibao Feng, Sunhee Ro, Jane Huang
  • Publication number: 20200368237
    Abstract: Disclosed herein is a method for the prevention, delay of progression or treatment of indolent or aggressive B-cell lymphomas in an individual in need thereof, comprising administering a Btk inhibitor (in particularly (S)-7-(1-actyloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo-[1,5-a]pyrimidine-3-carboxamide or a pharmaceutically acceptable salt thereof) in combination with an anti-PD-1 antibody. The potent and selective BTK inhibitor in combination with the anti-PD-1 antibody have a manageable toxicity profile in patients with indolent and aggressive lymphomas.
    Type: Application
    Filed: November 29, 2018
    Publication date: November 26, 2020
    Inventors: James HILGER, Xiaoping ZHANG, Shibao FENG, Sunhee RO, Jane HUANG
  • Publication number: 20140045138
    Abstract: An exemplary embodiment of the present invention is directed to a malleable flattened rectangular lingual retainer wire that is configured to be integrally shaped and bonded to the inside surfaces of teeth for a prolonged period of time. The lingual retainer wire acts to secure the teeth to one another in a manner that provides precise root position control. The lingual retainer wire is a single strand of wire that has been flattened in order to reduce its profile allowing the lingual retainer wire to be placed on the inside of either the upper or lower incisor teeth without interfering with occlusion.
    Type: Application
    Filed: August 9, 2012
    Publication date: February 13, 2014
    Inventors: Paul A. GANGE, James Hilgers
  • Publication number: 20090037836
    Abstract: A computer system for a system interaction matrix creation tool is provided. The computer system has a platform, at least one input device, and a central processing unit in communication with the platform and the at least one input device. The central processing unit is configured to display a system interaction matrix having a first dimension indexed to a plurality of affecting subsystems, and a second dimension indexed to a plurality of affected subsystems, receive a selection of one of the plurality affecting subsystems and a selection of one of the plurality of affected subsystems, and receive a selection of one of a plurality of types of interactions existing between the selected one of the plurality of affecting subsystems and the selected one of the plurality of affected subsystems. The central processing unit is further configured to receive a description of the selected interaction.
    Type: Application
    Filed: July 31, 2007
    Publication date: February 5, 2009
    Inventors: Anthony Duilio Moretti, Cole Douglas Hagen, Howard James Hilgers, David A. Guldan